Cargando…
Open-Label Fosmetpantotenate, a Phosphopantothenate Replacement Therapy in a Single Patient with Atypical PKAN
Objective. Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder with variable onset, rate of progression, and phenotypic expression. Later-onset, more slowly progressive PKAN often presents with neuropsychiatric as well as motor manifestations that include speec...
Autores principales: | Christou, Yiolanda-Panayiota, Tanteles, George A., Kkolou, Elena, Ormiston, Annita, Konstantopoulos, Kostas, Beconi, Maria, Marshall, Randall D., Plotkin, Horacio, Kleopa, Kleopas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439260/ https://www.ncbi.nlm.nih.gov/pubmed/28567317 http://dx.doi.org/10.1155/2017/3247034 |
Ejemplares similares
-
Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models
por: Elbaum, Daniel, et al.
Publicado: (2018) -
Prevalence of Anti-JC Virus (JCV) Antibodies in the Multiple Sclerosis (MS) Population in Cyprus: A Retrospective Study
por: Lambrianides, Sakis, et al.
Publicado: (2019) -
Mosaic Evolution of the Phosphopantothenate Biosynthesis Pathway in Bacteria and Archaea
por: Thomès, Luc, et al.
Publicado: (2020) -
Retrospective longitudinal study of ALS in Cyprus: Clinical characteristics, management and survival
por: Demetriou, Christiana A., et al.
Publicado: (2019) -
Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated Neurodegeneration
por: Klopstock, Thomas, et al.
Publicado: (2020)